Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
470
-
Total 13F shares, excl. options
-
95.8M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$11.7B
-
Value change
-
+$165M
-
Put/Call ratio
-
0.86
-
Number of buys
-
210
-
Number of sells
-
-232
-
Price
-
$122.03
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2019
540 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2019.
RESMED INC - Common Stock (RMD) has 470 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.8M shares
of 146M outstanding shares and own 65.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.3M shares), BlackRock Inc. (11.7M shares), WCM INVESTMENT MANAGEMENT, LLC (7.22M shares), STATE STREET CORP (6.31M shares), FMR LLC (6.12M shares), Capital World Investors (5.77M shares), BAILLIE GIFFORD & CO (4.82M shares), GEODE CAPITAL MANAGEMENT, LLC (2.09M shares), NORTHERN TRUST CORP (1.99M shares), and Invesco Ltd. (1.96M shares).
This table shows the top 470 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.